热门资讯> 正文

HCW Biologics GAAP每股收益为-16.16美元

2025-08-20 02:02

HCW Biologics press release (NASDAQ:HCWB): Q2 GAAP EPS of -$16.16.
Revenues for the second quarters ended June 30, 2025, and 2024 were $6,550 and $618,854, respectively.

More on HCW Biologics

Seeking Alpha’s Quant Rating on HCW Biologics
Historical earnings data for HCW Biologics
Financial information for HCW Biologics

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。